-
A paper on CTLA-4-binding cyclic peptides and their peptidomimetic small molecules has been published.
A paper on CTLA-4-binding cyclic peptides and their peptidom…… -
GeneFrontier will present the latest PUREfrex® technology at the conference in PEGS Boston
May 2 – 6, 2022, Boston, MA & ONLINEPEGS Boston: Confere…… -
Exhibition booth and Poster presentation at Cell Free Systems Conference
Cell Free Systems ConferenceDecember 4-6, 2019, Boston, MA U…… -
GeneFrontier presented in the poster session for PEGS Boston
April 08 - 12, 2019, Boston, MAPEGS: the essential protein e…… -
PepTalk-The Protein Science Week
GeneFrontier presented poster is available.Please visit our …… -
PUREfrex® 2.1 is newly launched
PUREfrex® 2.1 is newly launched in December 2017. The selec…… -
GeneFrontier presented in the poster session for PEGS Boston
GeneFrontier presented our latest and unpublished data in th…… -
GeneFrontier Announces the Second Alliance Regarding PUREfrex RD
April 22, 2013 GeneFrontier Corporation, a Japan-based biot…… -
Collaboration and License Agreement with the Global Pharmaceutical Company Regarding PUREfrex RD
Feb. 21, 2013 GeneFrontier Corporation, a Japan-based biote…… -
GeneFrontier Presented at BIO-Europe 2012
November 12 -14, 2012 BIO-Europe 2012 GeneFrontier introduc…… -
GeneFrontier Presented in Poster Sessions of PEGS 2012
April 30 – May 4, 2012 Eighth Annual PEGS GeneFrontier intr…… -
GeneFrontier Presented Our Technology at BIO-Europe 2011
October 31 – November 2, 2011 BIO-Europe® 2011 GeneFrontier…… -
GeneFrontier Presented in Poster Sessions of PEGS 2011
May 9-13, 2011 Seventh Annual PEGS GeneFrontier introduced ……
